PV
Palvella Therapeutics, Inc. (PVLA)
NASDAQ·Healthcare·Biotechnology
$128.11
-0.41%
Mkt Cap $1.50B
Analyst Ratings
Buy
23
Hold
0
Sell
0
Price Target (31 analysts)
$203.92
Range $143.00 – $255.00
Implied Upside
+59.2%
Consensus $203.92 vs current $128.11